COVID-19 2024 vaccine advice

29 February 2024 - The Australian Government has accepted the latest advice from the Australian Technical Advisory Group on Immunisation ...

Read more →

ATAGI recommendations on use of the Moderna and Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccines

20 November 2023 - Recommendations from the Australian Technical Advisory Group on Immunisation on the use of XBB 1.5 COVID-19 vaccines. ...

Read more →

New Covid-19 vaccines available to target current variants

20 November 2023 - The Australian Government has accepted the latest advice from the Australian Technical Advisory Group on Immunisation on ...

Read more →

End of COVID-19 emergency response

20 October 2023 - A statement from Australia's Chief Medical Officer, Professor Paul Kelly, on the end of the COVID-19 emergency ...

Read more →

Additional COVID-19 vaccine dose recommended for adults 75 years and over

1 September 2023 - The Australian Government has accepted advice from the Australian Technical Advisory Group on Immunisation (ATAGI) that all ...

Read more →

ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older

30 May 2023 - ATAGI has made recommendations on the use of bivalent COVID-19 vaccines as a primary course. ...

Read more →

COVID-19 vaccine safety report (6 April 2023)

6 April 2023 - To 2 April 2023, more than 44 million doses of Comirnaty (Pfizer) mRNA vaccines have been administered in ...

Read more →

COVID-19 vaccine safety report (23 March 2023)

23 March 2023 - To 19 March 2023, more than 44 million doses have been administered in Australia, as well ...

Read more →

COVID-19 vaccine safety report (9 March 2023)

9 March 2023 - To 5 March 2023, over 44 million doses have been administered in Australia, as well as about ...

Read more →

ATAGI recommendations on use of the Moderna bivalent (Original/Omicron BA.4/5) COVID-19 vaccine

28 February 2023 - Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Moderna bivalent ...

Read more →

Supplies secured of latest Moderna COVID-19 vaccine as recommended by Halton Review

28 February 2023 - The Australian Government has secured an additional 3 million doses of the latest Moderna Omicron-specific COVID-19 vaccine ...

Read more →

COVID-19 vaccine safety report (23 February 2023)

23 February 2023 - To 19 February 2023, over 44 million doses have been administered in Australia, as well as ...

Read more →

TGA grants provisional approval to Moderna’s COVID-19 bivalent (Spikevax Bivalent Original/Omicron BA.4-5) booster dose vaccine

20 February 2023 - On 17 February, 2023, the TGA granted provisional approval to Moderna’s bivalent COVID-19 vaccine: elasomeran and ...

Read more →

COVID-19 vaccine safety report (09 February 2023)

9 February 2023 - To 5 February 2023, over 44 million doses of Comirnaty have been administered in Australia, as well ...

Read more →

ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine

8 February 2023 - On 20 January 2023, the TGA provisionally approved the Pfizer (Comirnaty) Bivalent Original/Omicron BA.4/5 vaccine for use ...

Read more →